Medifacts International Drives Innovation in Telemedicine for Clinical Trials

Published: Dec 16, 2009

ROCKVILLE, Md.--(BUSINESS WIRE)--MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiovascular diagnostic services, today announced that they are once again leading the Cardiovascular Safety Services marketplace in innovation, expertise, and execution - this time with new innovations in the use of telemedicine, T-SMBP (Telemonitoring Self Measured Blood Pressure), in clinical trials.

Back to news